Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about CYBN

Recent news which mentions CYBN

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Cybin Inc. Begins Phase 3 Trials, Betting Big On CYB003 To Treat Depression
Tickers CYBN
Tags Markets Doug Drysdale CYBN
From Benzinga
EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines Program
Tickers CYBN NEWS
Tags Health Care Benzinga Market News
From Benzinga
Leadership Shake-Ups In Cannabis And Psychedelics: Maryland's Cannabis Chief Resigns, Costly Legal Battle In MA Drags On & More
Tickers AAWH CCC CYBN NEWS
Tags News Cannabis Movers and Shakers Entrepreneurship
From Benzinga
CYBN Stock Earnings: Cybin Beats EPS for Q1 2024
Tickers CYBN
Tags Market News CYBN NYSE:CYBN
From InvestorPlace
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
Tickers ATAI CMPS CYBN HAVLF
Tags Top Stories ATAI MNMD
From Benzinga
3 Biotech Stocks That Could Make Your Summer Unforgettable
Tickers CYBN GPCR JEF LLY
Tags SNDX NASDAQ:GPCR,NYSEAMERICAN:CYBN,NYSE:LLY,NASDAQ:SNDX,NYSE:JEF CYBN
From InvestorPlace
Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns
Tickers ATAI CYBN GHRS
Tags Market News NASDAQ:ATAI,NASDAQ:GHRS,NYSEAMERICAN:CYBN Stocks to Buy
From InvestorPlace
3 Psychedelic Stocks to Buy on the Dip: Summer 2024
Tickers ATAI CMPS CYBN
Tags CYBN CMPS ATAI
From InvestorPlace
CYBN Stock Earnings: Cybin Beats EPS for Q4 2023
Tickers CYBN
Tags Market News CYBN NYSEMKT:CYBN
From InvestorPlace
Biopharma Co. Cybin Reports $78M Loss Amid Accelerating Expansion In Psychedelic Therapies, Drug Development
Tickers CYBN
Tags Cannabis Earnings Market News
From Benzinga
Latest Executive Cannabis Changes You Should Know About: Curaleaf, Planet 13 Elect Directors And More
Tickers CURA CURLF CWBHF CWEB
Tags GRAM cannabis appointments TILT
From Benzinga
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
Tickers ATAI CYBN MDMA MNMD
Tags Specialty ETFs Psychedelics PSIL
From Benzinga
Pot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In Oregon
Tickers ATAI CMPS CYBN KAYS
Tags Benzinga Oregon Health Authority Fifth Dimension Therapeutics
From Benzinga
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Tickers CMND CMPS CYBN FLHLF
Tags SILO Market News Cannabis
From Benzinga
3 Penny Stocks That Could Be Multibaggers in the Making: March Edition
Tickers CLNN CYBN LIFE
Tags Stocks to Buy NASDAQ:CLNN,NASDAQ:LIFE,NYSEAMERICAN:CYBN Market News
From InvestorPlace
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Tickers ATAI CMND CMPS CYBN
Tags IXHL Psychedelics Reform MNMD
From Benzinga
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement
Tickers CMPS CYBN MNMD
Tags Legal MNMD CYBN
From Benzinga
3 High-Potential Penny Stocks to Turn $1000 into $1 million
Tickers CYBN GOEV JOB
Tags Stocks to Buy Uncategorized Market News
From InvestorPlace
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Tickers ATAI CMND CMPS CYBN
Tags psilocybin therapy Benzinga SPRC
From Benzinga
Cybin Inc. Q3 Earnings: Clinical Advances Amid Financial Loss
Tickers CYBN NEWS
Tags Markets Opinion News
From Benzinga
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Tickers ATAI AWKNF CMND CYBN
Tags Legal MYCOF ATAI
From Benzinga
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
Tickers ATAI CMND CMPS CYBN
Tags IXHL Legal MNMD
From Benzinga
FDA Green Lights Cybin's Psychedelic Clinical Study Assessing Generalized Anxiety
Tickers CYBN NEWS
Tags CYBN DMT Analog News
From Benzinga
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
Tickers ATAI CMND CMPS CYBN
Tags CYBN CMPS Psychedelics Research
From Benzinga
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
Tickers ATAI CMND CMPS CYBN
Tags VA Markets ENVB
From Benzinga
30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond
Tickers CYBN ENVB NEWS NUMIF
Tags Cannabis Psychedelics Investing Market News
From Benzinga
Cybin Inc's Two Deuterated Psychedelic Molecules Achieve Positive Topline Clinical Results
Tickers CYBN NEWS
Tags Management CYBN News
From Benzinga
Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD
Tickers ATAI CMPS CYBN DMTTF
Tags Penny Stocks Joe Samberg Rick Doblin
From Benzinga
Psychedelic Stock Gainers And Losers From January 1, 2024
Tickers ATAI CMPS CYBN GHRS
Tags Benzinga GHRS Markets
From Benzinga
Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential
Tickers BIIB CYBN SUPN
Tags CYBN BIIB NYSE:CYBN,NASDAQ:SUPN,NASDAQ:BIIB
From InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.